image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 167.86
-2.38 %
$ 4.11 B
Market Cap
-58.49
P/E
1. INTRINSIC VALUE

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.[ Read More ]

The intrinsic value of one ICUI stock under the base case scenario is HIDDEN Compared to the current market price of 168 USD, ICU Medical, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ICUI

image
FINANCIALS
2.26 B REVENUE
-0.92%
22.8 M OPERATING INCOME
362.24%
-29.7 M NET INCOME
60.08%
166 M OPERATING CASH FLOW
367.51%
-87.9 M INVESTING CASH FLOW
95.39%
-36 M FINANCING CASH FLOW
-2.20%
589 M REVENUE
-1.23%
8.24 M OPERATING INCOME
7.07%
-33 M NET INCOME
-54.08%
36.1 M OPERATING CASH FLOW
-55.95%
-22.9 M INVESTING CASH FLOW
-5.38%
-10.4 M FINANCING CASH FLOW
0.04%
Balance Sheet Decomposition ICU Medical, Inc.
image
Current Assets 1.22 B
Cash & Short-Term Investments 255 M
Receivables 164 M
Other Current Assets 802 M
Non-Current Assets 3.16 B
Long-Term Investments 39.3 M
PP&E 686 M
Other Non-Current Assets 2.43 B
Current Liabilities 482 M
Accounts Payable 150 M
Short-Term Debt 72 M
Other Current Liabilities 260 M
Non-Current Liabilities 1.77 B
Long-Term Debt 1.63 B
Other Non-Current Liabilities 140 M
EFFICIENCY
Earnings Waterfall ICU Medical, Inc.
image
Revenue 2.26 B
Cost Of Revenue 1.52 B
Gross Profit 740 M
Operating Expenses 717 M
Operating Income 22.8 M
Other Expenses 52.5 M
Net Income -29.7 M
RATIOS
32.75% GROSS MARGIN
32.75%
1.01% OPERATING MARGIN
1.01%
-1.31% NET MARGIN
-1.31%
-1.40% ROE
-1.40%
-0.68% ROA
-0.68%
0.23% ROIC
0.23%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ICU Medical, Inc.
image
Net Income -29.7 M
Depreciation & Amortization 229 M
Capital Expenditures -93.7 M
Stock-Based Compensation 40.6 M
Change in Working Capital -136 M
Others -47.7 M
Free Cash Flow 72.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets ICU Medical, Inc.
image
Wall Street analysts predict an average 1-year price target for ICUI of $172 , with forecasts ranging from a low of $135 to a high of $198 .
ICUI Lowest Price Target Wall Street Target
135 USD -19.58%
ICUI Average Price Target Wall Street Target
172 USD 2.47%
ICUI Highest Price Target Wall Street Target
198 USD 17.96%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership ICU Medical, Inc.
image
Sold
0-3 MONTHS
6.57 M USD 2
3-6 MONTHS
3.5 M USD 4
6-9 MONTHS
184 M USD 7
9-12 MONTHS
152 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 weeks ago
Nov 01, 2024
Sell 722 K USD
Jain Vivek
Chairman and CEO
- 4228
170.7504 USD
2 weeks ago
Nov 01, 2024
Sell 713 K USD
Jain Vivek
Chairman and CEO
- 4147
171.9086 USD
2 weeks ago
Nov 01, 2024
Sell 412 K USD
Jain Vivek
Chairman and CEO
- 2386
172.7628 USD
2 weeks ago
Nov 01, 2024
Sell 215 K USD
Jain Vivek
Chairman and CEO
- 1239
173.597 USD
1 month ago
Oct 01, 2024
Sell 738 K USD
Jain Vivek
Chairman and CEO
- 4156
177.498 USD
1 month ago
Oct 01, 2024
Sell 657 K USD
Jain Vivek
Chairman and CEO
- 3681
178.4898 USD
1 month ago
Oct 01, 2024
Sell 605 K USD
Jain Vivek
Chairman and CEO
- 3375
179.158 USD
1 month ago
Oct 01, 2024
Sell 142 K USD
Jain Vivek
Chairman and CEO
- 788
180.481 USD
2 months ago
Sep 03, 2024
Sell 611 K USD
Jain Vivek
Chairman and CEO
- 3755
162.694 USD
2 months ago
Sep 03, 2024
Sell 726 K USD
Jain Vivek
Chairman and CEO
- 4440
163.587 USD
2 months ago
Sep 03, 2024
Sell 624 K USD
Jain Vivek
Chairman and CEO
- 3805
164.0731 USD
2 months ago
Aug 30, 2024
Sell 408 K USD
Woolson Daniel
VP, GM-Infusion Capital
- 2502
163.2175 USD
3 months ago
Aug 16, 2024
Sell 1.87 M USD
Jain Vivek
Chairman and CEO
- 12000
156.04 USD
3 months ago
Aug 08, 2024
Sell 295 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 2050
144.1102 USD
5 months ago
May 30, 2024
Sell 1.09 M USD
Voigtlander Christian B.
Chief Operating Officer
- 10507
103.8504 USD
5 months ago
May 30, 2024
Sell 212 K USD
Voigtlander Christian B.
Chief Operating Officer
- 2032
104.4923 USD
6 months ago
May 16, 2024
Sell 31.5 K USD
FINNEY ELISHA W
Director
- 300
104.9475 USD
6 months ago
May 10, 2024
Sell 211 K USD
Sousa Ben
Chief Information Officer
- 2000
105.545 USD
8 months ago
Mar 15, 2024
Sell 77.7 K USD
Woolson Daniel
VP, GM-Infusion Capital
- 791
98.2715 USD
8 months ago
Mar 14, 2024
Sell 813 K USD
LOPEZ GEORGE A
Director
- 7978
101.8728 USD
8 months ago
Mar 12, 2024
Sell 154 K USD
LOPEZ GEORGE A
Director
- 1522
101.509 USD
8 months ago
Mar 11, 2024
Sell 197 K USD
LOPEZ GEORGE A
Director
- 1890
104.2159 USD
8 months ago
Mar 12, 2024
Sell 154 K USD
LOPEZ GEORGE A
Director
- 1522
101.509 USD
8 months ago
Mar 08, 2024
Sell 345 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 3300
104.5722 USD
8 months ago
Mar 04, 2024
Sell 753 K USD
LOPEZ GEORGE A
Director
- 7051
106.7923 USD
8 months ago
Mar 07, 2024
Sell 2 M USD
LOPEZ GEORGE A
Director
- 18954
105.767 USD
8 months ago
Mar 08, 2024
Sell 1.63 M USD
LOPEZ GEORGE A
Director
- 15372
105.9364 USD
8 months ago
Mar 04, 2024
Sell 735 K USD
Voigtlander Christian B.
Chief Operating Officer
- 6887
106.7684 USD
8 months ago
Mar 04, 2024
Sell 699 K USD
Voigtlander Christian B.
Chief Operating Officer
- 6497
107.5973 USD
8 months ago
Mar 04, 2024
Sell 23.7 K USD
Voigtlander Christian B.
Chief Operating Officer
- 219
108.296 USD
8 months ago
Feb 29, 2024
Sell 88 M USD
SMITHS GROUP PLC
other: Former 10% Owner
- 830000
106.075 USD
8 months ago
Feb 29, 2024
Sell 88 M USD
Smiths Group International Holdings Ltd
other: Former 10% Owner
- 830000
106.075 USD
11 months ago
Dec 01, 2023
Sell 152 K USD
Woolson Daniel
VP, GM-Infusion Capital
- 1729
88.0256 USD
1 year ago
Sep 08, 2023
Sell 795 K USD
Voigtlander Christian B.
Chief Operating Officer
- 6162
128.9735 USD
1 year ago
Sep 08, 2023
Sell 89.2 K USD
Voigtlander Christian B.
Chief Operating Officer
- 688
129.6444 USD
1 year ago
Jul 12, 2023
Sell 5.4 M USD
Jain Vivek
Chairman and CEO
- 30000
180.024 USD
1 year ago
Jun 14, 2023
Sell 19.5 K USD
Jain Vivek
Chairman and CEO
- 100
194.73 USD
1 year ago
Jun 14, 2023
Sell 469 K USD
Jain Vivek
Chairman and CEO
- 2418
194.0219 USD
1 year ago
Jun 14, 2023
Sell 407 K USD
Jain Vivek
Chairman and CEO
- 2104
193.296 USD
1 year ago
Jun 14, 2023
Sell 521 K USD
Jain Vivek
Chairman and CEO
- 2781
187.434 USD
1 year ago
Jun 14, 2023
Sell 307 K USD
Jain Vivek
Chairman and CEO
- 1601
192.0613 USD
1 year ago
Jun 14, 2023
Sell 678 K USD
Jain Vivek
Chairman and CEO
- 3637
186.5029 USD
1 year ago
Jun 14, 2023
Sell 1.25 M USD
Jain Vivek
Chairman and CEO
- 6712
185.7305 USD
1 year ago
Jun 14, 2023
Sell 149 K USD
Jain Vivek
Chairman and CEO
- 785
189.3167 USD
1 year ago
Jun 14, 2023
Sell 324 K USD
Jain Vivek
Chairman and CEO
- 1699
190.482 USD
1 year ago
Jun 14, 2023
Sell 1.54 M USD
Jain Vivek
Chairman and CEO
- 8163
188.5155 USD
1 year ago
Jun 07, 2023
Sell 36.9 K USD
FINNEY ELISHA W
Director
- 194
190.41 USD
1 year ago
Apr 11, 2023
Sell 43.8 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 250
175 USD
1 year ago
Apr 05, 2023
Sell 77.9 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 458
170 USD
1 year ago
Feb 02, 2023
Sell 346 K USD
Woolson Daniel
VP, GM-Infusion Capital
- 1731
200 USD
2 years ago
Nov 15, 2022
Sell 52 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 325
160.12 USD
2 years ago
May 12, 2022
Bought 2.97 K USD
LOPEZ GEORGE A
Director
+ 17
174.66 USD
2 years ago
May 12, 2022
Bought 1.62 M USD
LOPEZ GEORGE A
Director
+ 9329
174.1707 USD
2 years ago
May 12, 2022
Bought 1.23 M USD
LOPEZ GEORGE A
director:
+ 7092
173.0744 USD
2 years ago
May 12, 2022
Bought 847 K USD
LOPEZ GEORGE A
Director
+ 4917
172.2362 USD
2 years ago
May 12, 2022
Bought 765 K USD
LOPEZ GEORGE A
Director
+ 4480
170.7855 USD
2 years ago
May 12, 2022
Sell 130 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 750
173.56 USD
2 years ago
May 11, 2022
Sell 37 K USD
FINNEY ELISHA W
director:
- 217
170.53 USD
2 years ago
Mar 03, 2022
Sell 8.64 M USD
Jain Vivek
Chairman and CEO
- 36000
240 USD
2 years ago
Dec 29, 2021
Sell 2.56 M USD
Jain Vivek
Chairman and CEO
- 10677
240.0012 USD
2 years ago
Dec 30, 2021
Sell 278 K USD
Jain Vivek
Chairman and CEO
- 1159
240 USD
3 years ago
Nov 03, 2021
Sell 2.88 M USD
Jain Vivek
Chairman and CEO
- 12000
240 USD
3 years ago
Nov 03, 2021
Sell 2.88 M USD
Jain Vivek
Chairman and CEO
- 12000
240.0038 USD
3 years ago
Sep 15, 2021
Sell 524 K USD
SWINNEY ROBERT S
Director
- 2157
243 USD
3 years ago
Sep 14, 2021
Sell 587 K USD
FINNEY ELISHA W
Director
- 2424
242.2014 USD
3 years ago
Sep 10, 2021
Sell 37.8 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 151
250.2341 USD
3 years ago
Sep 10, 2021
Sell 101 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 401
251.2653 USD
3 years ago
Sep 10, 2021
Sell 62.7 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 248
252.8165 USD
3 years ago
Jun 03, 2021
Sell 60.6 K USD
SWINNEY ROBERT S
Director
- 300
202.1567 USD
3 years ago
Jun 03, 2021
Sell 505 K USD
SWINNEY ROBERT S
Director
- 2485
203.067 USD
3 years ago
Jun 03, 2021
Sell 43.9 K USD
SWINNEY ROBERT S
Director
- 215
204.0815 USD
3 years ago
Jun 03, 2021
Sell 262 K USD
SWINNEY ROBERT S
Director
- 1293
202.9479 USD
3 years ago
Jun 03, 2021
Sell 42.2 K USD
SWINNEY ROBERT S
Director
- 207
204.0404 USD
3 years ago
May 11, 2021
Sell 197 K USD
Sanzone Virginia Ruth
VP, General Counsel
- 983
200.109 USD
3 years ago
Apr 22, 2021
Sell 1.09 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 5089
213.581 USD
3 years ago
Apr 22, 2021
Sell 1.06 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 4926
214.636 USD
3 years ago
Apr 22, 2021
Sell 424 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1970
215.2896 USD
3 years ago
Apr 23, 2021
Sell 566 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 2671
211.8199 USD
3 years ago
Apr 23, 2021
Sell 1.45 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 6804
213.0438 USD
3 years ago
Apr 23, 2021
Sell 754 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 3529
213.7942 USD
3 years ago
Apr 23, 2021
Sell 2.36 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 11
214.64 USD
3 years ago
Apr 15, 2021
Sell 130 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 630
206.7094 USD
3 years ago
Apr 15, 2021
Sell 1.75 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 8412
207.6788 USD
3 years ago
Apr 15, 2021
Sell 1.18 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 5658
208.6166 USD
3 years ago
Apr 15, 2021
Sell 41.9 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 200
209.31 USD
3 years ago
Apr 16, 2021
Sell 302 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1454
207.6511 USD
3 years ago
Apr 16, 2021
Sell 204 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 977
208.7857 USD
3 years ago
Apr 16, 2021
Sell 545 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 2597
210.0092 USD
3 years ago
Apr 16, 2021
Sell 339 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1608
211.0294 USD
3 years ago
Apr 16, 2021
Sell 403 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1905
211.81 USD
3 years ago
Apr 16, 2021
Sell 332 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1559
212.7818 USD
3 years ago
Apr 08, 2021
Sell 1.2 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 5914
203.216 USD
3 years ago
Apr 08, 2021
Sell 585 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 2868
203.9982 USD
3 years ago
Apr 08, 2021
Sell 229 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1118
204.9901 USD
3 years ago
Apr 09, 2021
Sell 944 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 4650
203.1075 USD
3 years ago
Apr 09, 2021
Sell 1.09 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 5350
203.8431 USD
3 years ago
Apr 09, 2021
Sell 81.9 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 400
204.7 USD
3 years ago
Apr 12, 2021
Sell 34.3 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 167
205.2256 USD
3 years ago
Apr 12, 2021
Sell 855 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 4149
206.1047 USD
3 years ago
Apr 12, 2021
Sell 79.4 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 384
206.7763 USD
3 years ago
Apr 01, 2021
Sell 81.2 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 400
203 USD
3 years ago
Apr 01, 2021
Sell 278 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1347
206.0988 USD
3 years ago
Apr 01, 2021
Sell 853 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 4119
207.1274 USD
3 years ago
Apr 01, 2021
Sell 497 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 2389
207.9011 USD
3 years ago
Apr 01, 2021
Sell 1.2 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 5745
208.9299 USD
3 years ago
Apr 01, 2021
Sell 168 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 800
209.6247 USD
3 years ago
Apr 05, 2021
Sell 636 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 3118
204.1066 USD
3 years ago
Apr 05, 2021
Sell 1.3 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 6365
205.0096 USD
3 years ago
Apr 05, 2021
Sell 92.1 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 448
205.6136 USD
3 years ago
Apr 05, 2021
Sell 50.6 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 244
207.448 USD
3 years ago
Apr 05, 2021
Sell 5.21 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 25
208.5 USD
3 years ago
Mar 02, 2021
Sell 310 K USD
SWINNEY ROBERT S
Director
- 1500
207 USD
3 years ago
Jan 08, 2021
Sell 8.49 M USD
Jain Vivek
Chairman and CEO
- 38591
220 USD
3 years ago
Jan 04, 2021
Sell 167 K USD
Jain Vivek
Chairman and CEO
- 800
209.2382 USD
3 years ago
Jan 04, 2021
Sell 147 K USD
Jain Vivek
Chairman and CEO
- 700
210.3021 USD
3 years ago
Jan 04, 2021
Sell 529 K USD
Jain Vivek
Chairman and CEO
- 2500
211.5388 USD
3 years ago
Jan 04, 2021
Sell 1.01 M USD
Jain Vivek
Chairman and CEO
- 4759
212.0985 USD
3 years ago
Jan 04, 2021
Sell 151 K USD
Jain Vivek
Chairman and CEO
- 708
213.4529 USD
3 years ago
Jan 04, 2021
Sell 64.3 K USD
Jain Vivek
Chairman and CEO
- 300
214.3333 USD
3 years ago
Jan 04, 2021
Sell 330 K USD
Jain Vivek
Chairman and CEO
- 1533
215.5755 USD
3 years ago
Jan 04, 2021
Sell 43.3 K USD
Jain Vivek
Chairman and CEO
- 200
216.4198 USD
3 years ago
Dec 04, 2020
Sell 1.79 M USD
Jain Vivek
Chairman and CEO
- 9200
195 USD
4 years ago
Nov 11, 2020
Sell 326 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1695
192.3573 USD
4 years ago
Nov 11, 2020
Sell 213 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1101
193.0674 USD
4 years ago
Nov 11, 2020
Sell 947 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 4878
194.0773 USD
4 years ago
Nov 11, 2020
Sell 50.6 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 258
196.2704 USD
4 years ago
Nov 11, 2020
Sell 394 USD
LOPEZ GEORGE A
director, 10 percent owner:
- 2
197 USD
4 years ago
Nov 12, 2020
Sell 1.17 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 6036
194.0869 USD
4 years ago
Nov 11, 2020
Sell 1.47 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 7566
193.8561 USD
4 years ago
Nov 12, 2020
Sell 1.65 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 8439
194.9285 USD
4 years ago
Nov 11, 2020
Sell 1.46 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 7500
194.834 USD
4 years ago
Nov 12, 2020
Sell 495 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 2525
196.0538 USD
4 years ago
Nov 06, 2020
Sell 2.24 M USD
Jain Vivek
Chairman and CEO
- 11500
195 USD
4 years ago
Oct 16, 2020
Sell 56 K USD
SWINNEY ROBERT S
Director
- 277
202.22 USD
4 years ago
Oct 09, 2020
Sell 2.24 M USD
Jain Vivek
Chairman and CEO
- 11500
195 USD
4 years ago
Sep 01, 2020
Sell 1.66 M USD
Jain Vivek
Chairman and CEO
- 8456
196.744 USD
4 years ago
Sep 01, 2020
Sell 373 K USD
Jain Vivek
Chairman and CEO
- 1886
197.7553 USD
4 years ago
Sep 01, 2020
Sell 99.3 K USD
Jain Vivek
Chairman and CEO
- 500
198.6 USD
4 years ago
Sep 01, 2020
Sell 132 K USD
Jain Vivek
Chairman and CEO
- 658
199.9288 USD
4 years ago
Aug 27, 2020
Sell 2.24 M USD
Jain Vivek
Chairman and CEO
- 11500
195 USD
4 years ago
Aug 13, 2020
Sell 150 K USD
FINNEY ELISHA W
Director
- 790
190 USD
4 years ago
Jul 16, 2020
Sell 56.5 K USD
SWINNEY ROBERT S
Director
- 300
188.46 USD
4 years ago
Jun 09, 2020
Sell 966 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 4995
193.2944 USD
4 years ago
Jun 09, 2020
Sell 98.3 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 505
194.5837 USD
4 years ago
Jun 09, 2020
Sell 235 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1200
196.1643 USD
4 years ago
Jun 09, 2020
Sell 217 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1100
197.1898 USD
4 years ago
Jun 08, 2020
Sell 244 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1200
203.113 USD
4 years ago
Jun 09, 2020
Sell 199 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 1000
198.9338 USD
4 years ago
Jun 02, 2020
Sell 731 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 3654
200.1506 USD
4 years ago
Jun 02, 2020
Sell 93.4 K USD
LOPEZ GEORGE A
director, 10 percent owner:
- 464
201.3915 USD
4 years ago
Jun 03, 2020
Sell 1.86 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 9331
199 USD
4 years ago
Jun 01, 2020
Sell 2.5 M USD
Jain Vivek
Chairman and CEO
- 12232
204.1759 USD
4 years ago
Jun 01, 2020
Sell 561 K USD
Jain Vivek
Chairman and CEO
- 2768
202.5189 USD
4 years ago
May 28, 2020
Sell 3.27 M USD
LOPEZ GEORGE A
director, 10 percent owner:
- 16548
197.3739 USD
4 years ago
May 28, 2020
Sell 594 USD
LOPEZ GEORGE A
director, 10 percent owner:
- 3
198.09 USD
7. News
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript ICU Medical Inc. (NASDAQ:ICUI ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Eric Fleming - Raymond James Larry Solow - CJS Securities Kristen Stewart - CL King Mike Matson - Needham and Company Michael Toomey - Jefferies Operator Good day, everyone, and welcome to today's ICU Medical Inc.'s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 4 days ago
ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates ICU Medical (ICUI) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago. zacks.com - 4 days ago
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. Joint venture becomes part of a global manufacturing network with scale and redundancy Intends to add long-term supply resiliency and accelerate IV solutions new product development in North America Combines Otsuka Pharmaceutical Factory, Inc.'s expertise and global manufacturing scale with ICU Medical's strong North American production and distribution ICU Medical to provide commercial services to the joint venture Expected to become operationally effective in early Q2 2025 Full presentation available for view here SAN CLEMENTE, Calif. prnewswire.com - 4 days ago
ICU Medical to Participate at the UBS Global Healthcare Conference SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes, California, November 11-14, 2024. ICU Medical's presentation will be on Wednesday, November 13, 2024 at 4:15 p.m. PT (7:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, November 13, 2024. globenewswire.com - 1 week ago
ICU Medical (ICUI) Expected to Beat Earnings Estimates: Should You Buy? ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call. globenewswire.com - 2 weeks ago
Will ICU Medical (ICUI) Beat Estimates Again in Its Next Earnings Report? ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 4 weeks ago
ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death. zacks.com - 1 month ago
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run? ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com - 2 months ago
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run? ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com - 2 months ago
Is ICU Medical (ICUI) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 months ago
ICU Medical to Participate in Upcoming Investor Conferences SAN CLEMENTE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: globenewswire.com - 2 months ago
8. Profile Summary

ICU Medical, Inc. ICUI

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 4.11 B
Dividend Yield 0.00%
Description ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Contact 951 Calle Amanecer, San Clemente, CA, 92673 https://www.icumed.com
IPO Date March 31, 1992
Employees 14000
Officers Mr. Brian Michael Bonnell Chief Financial Officer & Treasurer Mr. Christian B. Voigtlander Chief Operating Officer Ms. Virginia Ruth Sanzone Corporate Vice President, General Counsel, Secretary & Compliance Officer Mr. Daniel Woolson President Mr. Vivek Jain Chief Executive Officer & Chairman of the Board